en Cafedrine

Cafedrine
Clinical data
Trade names	Akrinor, Bifort, Praxinor
Other names	Caphedrine; Cafedrin; Caphedrin; Kafedrin; Norephedrino-ethyltheophylline; 7-(2-(β-Hydroxy-α-methylphen-ethylamino)ethyl)theophylline
ATC code	C01CA21 (WHO) ;
Identifiers
	IUPAC name (RS)-7-[2-[(1-hydroxy-1-phenylpropan-2-yl)amino]ethyl]-1,3-dimethylpurine-2,6-dione;
CAS Number	58166-83-9 ;
PubChem CID	5489638;
ChemSpider	4590188 ;
UNII	0UYY5V4U2Q;
ChEMBL	ChEMBL2104207 ;
Chemical and physical data
Formula	C18H23N5O3
Molar mass	357.414 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C(CN[C@H]([C@H](O)C1=CC=CC=C1)C)N2C3=C(N(C)C(=O)N(C)C3=O)N=C2;
	InChI InChI=1S/C18H23N5O3/c1-12(15(24)13-7-5-4-6-8-13)19-9-10-23-11-20-16-14(23)17(25)22(3)18(26)21(16)2/h4-8,11-12,15,19,24H,9-10H2,1-3H3/t12-,15-/m0/s1 ; Key:UJSKUDDDPKGBJY-WFASDCNBSA-N ;
	(what is this?) (verify)

Cafedrine (INNTooltip International Nonproprietary Name, BANTooltip British Approved Name), sold under the brand name Akrinor among others, is a chemical linkage of norephedrine and theophylline and is a cardiac stimulant and antihypotensive agent used to increase blood pressure in people with hypotension.^[1]^[2]^[3]^[4] It has been marketed in Europe, South Africa, and Indonesia.^[4]^[5]

There has been concern about cafedrine as a potential performance-enhancing drug and doping agent in sports.^[6]

References

^ Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 205. ISBN 978-1-4757-2085-3. Retrieved 29 August 2024.
^ Pharmaceutical Manufacturing Encyclopedia. Volumes 1-4. Elsevier Science. 2013. p. 785. ISBN 978-0-8155-1856-3. Retrieved 29 August 2024.
^ Morton IK, Hall JM (1999). "Calcitonin gene-related peptide receptor antagonist". Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Dordrecht: Springer Netherlands. p. 59. ISBN 9789401144391.
^ ^a ^b Schweizerischer Apotheker-Verein (2000). Index Nominum 2000: International Drug Directory. Index nominum. Medpharm Scientific Publishers. p. 157. ISBN 978-3-88763-075-1. Retrieved 29 August 2024.
^ "Cafedrine". Drugs.com. Retrieved 29 August 2024.
^ Wilson W, Derse E (2001). Doping in Elite Sport: The Politics of Drugs in the Olympic Movement. Human Kinetics. p. 15. ISBN 978-0-7360-0329-2. Retrieved 29 August 2024.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.